KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 103 filers reported holding KYMERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,232,444 | -61.7% | 88,665 | -36.7% | 0.00% | – |
| Q2 2023 | $3,219,153 | -60.7% | 140,024 | -49.4% | 0.00% | -100.0% |
| Q1 2023 | $8,201,228 | +58.8% | 276,788 | +33.8% | 0.00% | 0.0% |
| Q4 2022 | $5,163,800 | +88.9% | 206,883 | +64.7% | 0.00% | – |
| Q3 2022 | $2,733,000 | +16.5% | 125,576 | +5.4% | 0.00% | – |
| Q2 2022 | $2,346,000 | -57.1% | 119,113 | -7.8% | 0.00% | -100.0% |
| Q1 2022 | $5,470,000 | +19.0% | 129,238 | +78.5% | 0.00% | – |
| Q4 2021 | $4,598,000 | +117.4% | 72,420 | +101.1% | 0.00% | – |
| Q3 2021 | $2,115,000 | +422.2% | 36,006 | +331.1% | 0.00% | – |
| Q2 2021 | $405,000 | -67.8% | 8,352 | -74.2% | 0.00% | – |
| Q1 2021 | $1,257,000 | +432.6% | 32,355 | +750.6% | 0.00% | – |
| Q4 2020 | $236,000 | +198.7% | 3,804 | +55.5% | 0.00% | – |
| Q3 2020 | $79,000 | – | 2,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
| BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
| Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
| Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
| Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
| CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
| Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
| Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
| Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |